Quality is a critical aspect of the pharmaceutical and life sciences industries, with any compromise in standards potentially leading to severe consequences. WuXi AppTec, a prominent global CRDMO, is dedicated to upholding the highest quality standards in drug development and manufacturing to ensure the safety and efficacy of treatments for patients worldwide.
With a vision of “every drug can be made and every disease can be treated,” WuXi AppTec recognizes the importance of quality as the cornerstone of its operations. The company serves a diverse range of partners across more than 30 countries, supporting them in delivering innovative therapies to the market. To achieve this, WuXi AppTec maintains a stringent commitment to quality and compliance, aligning its processes with global regulatory standards.
As the landscape of new drug R&D evolves towards a more efficient model, WuXi AppTec has expanded its global footprint to meet the increasing demands of clients. This expansion has enabled the company to facilitate the entry of drugs into global markets while ensuring that its quality and compliance systems meet the rigorous requirements of regulatory authorities worldwide.
WuXi AppTec’s unwavering dedication to quality is evident in its track record of successfully passing inspections by major regulatory bodies such as the US FDA, EU EMA, China NMPA, and Japan PMDA. The company’s facilities are certified to adhere to GMP, GLP, GCP, ISO 9001, and ISO 13485 standards, demonstrating its commitment to excellence in every aspect of its operations.
The success of WuXi AppTec in global regulatory audits and certifications is exemplified by its facilities in different regions. For instance, the site in Couvet, Switzerland, specializing in oral solid dosage production, has maintained a flawless record with no observations from FDA inspections. Similarly, facilities in Munich, Germany, and Changzhou and Taixing, China, have also received accolades for their adherence to quality standards.
To replicate its high-quality system across new facilities, WuXi AppTec emphasizes the importance of fostering a pervasive quality culture, providing systematic training, and implementing rigorous supply chain quality control measures. By ingraining quality into every aspect of its operations, the company ensures that all employees are aligned with its commitment to excellence.
Through its robust quality management system, comprehensive training programs, and stringent supply chain controls, WuXi AppTec continues to set the standard for quality in the CRDMO market. Its consistent performance in quality audits and inspections reinforces its position as a trusted partner for pharmaceutical companies seeking reliable and compliant manufacturing services.
In conclusion, WuXi AppTec’s global blueprint for trust and excellence in quality is a testament to its dedication to ensuring the safety and efficacy of treatments for patients worldwide. By upholding the highest standards in every aspect of its operations, the company has established itself as a leader in the pharmaceutical and life sciences industries, providing invaluable support to its partners in advancing healthcare innovation.